Cargando…
Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19
Autores principales: | Elmunzer, B. Joseph, Wolf, Bethany J., Scheiman, James M., Tierney, William M., Taylor, Jason R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659802/ https://www.ncbi.nlm.nih.gov/pubmed/33189702 http://dx.doi.org/10.1053/j.gastro.2020.11.007 |
Ejemplares similares
-
Preadmission predictors of severe COVID-19 in patients with diabetes mellitus
por: Shukla, Alpana P., et al.
Publicado: (2021) -
Effect of preadmission beta‐blockade on mortality in multiple trauma
por: Eriksson, M., et al.
Publicado: (2018) -
Mental health among Thai medical students: Preadmission evaluation and service utilization
por: Chiddaycha, Mayteewat, et al.
Publicado: (2021) -
Relationships between preadmission variables and academic outcomes for postbaccalaureate students in medical school
por: Schneid, Stephen D., et al.
Publicado: (2022) -
Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study
por: Eadie, Rebekah, et al.
Publicado: (2023)